From the Cosmetic Dermatology Archives

Botulinum Toxin Type A for Pediatric Hyperhidrosis

Hyperhidrosis is a stigmatizing medical disorder that can present in either adults or adolescents. Many of the treatment options that are approved by the US Food and Drug Administration for use in adults are neither officially approved for use in children nor well described in the literature. This article will provide an understanding of the impact of pediatric hyperhidrosis, review standard treatment options, and discuss the success one pediatric dermatology practice has had with the off-label use of botulinum toxin type A in children with hyperhidrosis.


 

Recommended Reading

Wine Analogy May Help Patients Grasp Filler Menu
MDedge Dermatology
FDA Approval of Reloxin Predicted Within Year
MDedge Dermatology
Cosmetic Result Analysis Depends On the Evaluator
MDedge Dermatology
Combined Therapy Optimizes Facial Rejuvenation
MDedge Dermatology
Dermatology at the Discount Store [editorial]
MDedge Dermatology
Exploring the Pitfalls in Clinical Cosmeceutical Research
MDedge Dermatology
Warning to Skin Surgeons: Avoid a Potentially Lethal Propranolol Hydrochloride&#150Epinephrine Interaction in Cosmetic Surgery
MDedge Dermatology
The Treatment of Photodamaged Skin With 5% 5-Fluorouracil Peels
MDedge Dermatology
Dermatologist as Entrepeneur
MDedge Dermatology
Atrophic Scar Revision Using Fractional Photothermolysis
MDedge Dermatology